Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors
Recruiting · NCT06195384 · Registry updated 2024-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 | 2024-06-26 | NCT06195384 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital of Guangzhou Medical University | 70 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Second Affiliated Hospital of Guangzhou Medical University | Guangzhou | China | 5 |